Literature DB >> 11138721

Placement matching: challenges and technical progress.

D R Gastfriend1, S H Lu, E Sharon.   

Abstract

Although it is highly desirable, standardized placement matching for substance use disorders poses challenges due to variability in settings, services, and syndromes; multidimensionality of clinical problems; multiplicity of outcome constructs; and temporal phenomena in the course of recovery. Despite these obstacles, progress is being made in developing patient placement criteria that are comprehensive with adequate reliability, feasibility, and resolution. With these methodological advances, it has been possible to initiate controlled research with placement criteria. The first such studies provide early evidence supporting such criteria and indicate areas for refinement.

Entities:  

Mesh:

Year:  2000        PMID: 11138721     DOI: 10.3109/10826080009148254

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  3 in total

1.  Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems.

Authors:  John Orwat; Richard Saitz; Christopher P Tompkins; Debbie M Cheng; Michael P Dentato; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2011-06-22

2.  Factors Associated With Use of ASAM Criteria and Service Provision in a National Sample of Outpatient Substance Abuse Treatment Units.

Authors:  Emmeline Chuang; Rebecca Wells; Jeffrey A Alexander; Peter D Friedmann; I-Heng Lee
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

3.  Patient-centered placement matching of alcohol-dependent patients based on a standardized intake assessment: process evaluation within an exploratory randomized controlled trial.

Authors:  Angela Buchholz; Michael Berner; Judith Dams; Anke Rosahl; Jochen Hempleman; Hans-Helmut König; Alexander Konnopka; Levente Kriston; Daniela Piontek; Jens Reimer; Jeanette Röhrig; Norbert Scherbaum; Anna Silkens; Ludwig Kraus
Journal:  BMC Psychiatry       Date:  2022-01-27       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.